Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDS Head of Department makes a splash in many international news sites with the published results of his 10 year ProtecT Study. A trial of 1,643 men with small prostate cancers resulted in the same 99% survival rate after a decade for those who had had surgery, radiotherapy or simply monitored the tumour.

Prof Freddie Hamdy © Academy of Medical Sciences
Professor Freddie Hamdy

Read more in the publication in the New England Journal of Medicine: http://www.nejm.org/doi/full/10.1056/NEJMoa1606220#t=article

BBC: http://www.bbc.co.uk/news/health-37362572

Guardian: https://www.theguardian.com/society/2016/sep/14/monitoring-prostate-cancer-effective-treatment

Telegraph: http://www.telegraph.co.uk/news/2016/09/14/prostate-cancer-survival-rates-equally-high-if-you-monitor-disea/

Financial Times: https://www.ft.com/content/34f1a9c8-78f7-11e6-a0c6-39e2633162d5

The Times: http://www.thetimes.co.uk/article/most-prostate-cancer-sufferers-can-avoid-pain-of-early-surgery-6rp8q8ml8

The Washington Post: https://www.washingtonpost.com/news/to-your-health/wp/2016/09/14/almost-all-men-with-early-prostate-cancer-survive-10-years-regardless-of-treatment/

New York Times online: http://www.nytimes.com/aponline/2016/09/14/health/ap-eu-med-prostate-cancer.html?_r=1 

NBC News online: http://www.nbcnews.com/health/health-news/all-prostate-cancer-treatments-about-equally-effective-study-finds-n648471

CBC online (Canada): http://www.cbc.ca/news/health/prostate-cancer-1.3762576 

Daily Telegraph Australia online: http://www.dailytelegraph.com.au/news/breaking-news/treat-or-monitor-early-prostate-cancer/news-story/9cff4fc64f9e56a5053a3103949a0ecf 

Channel NewsAsia online: http://www.channelnewsasia.com/news/world/prostate-cancer-options-show-little-difference-in-survival/3128170.html 

Further coverage

Call to watch and wait on male cancer

The Daily Mirror, 07/11/2017, p.15, Rosie Taylor

Too many men are diagnosed with prostate cancer when it will not harm them, Oxford University’s Professor Freddie Hamdy said. He argued that in many cases they should not be told they have it. He said that out of 500 diagnoses, 75% avoided treatment for three years and 44% for more than 10. He said patients “driven by anxiety” to tackle the cancer often opted for needless surgery or radiotherapy, leading to urinary and bowel problems and sexual dysfunction.

Ignore cancer call

The Sun, 07/11/2017, p.24, Unattributed

https://www.thesun.co.uk/news/4856964/men-prostrate-cancer-stress-oxford-professor/

Why not treating prostate cancer ‘is best for most men’

Daily Mail, 07/11/2017, p.27, Sophie Borland & Rosie Taylor

http://www.dailymail.co.uk/news/article-5056043/Prostate-cancer-patients-better-not-diagnosed.html

‘Better off undiagnosed’

Daily Mail (Ireland), 07/11/2017, p.12, Katie O’Neill

Similar stories

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Two NDS researchers receive prestigious MRC Clinical Research Training Fellowships

Miss Catherine Lovegrove and Dr Alexander Sagar from the Nuffield Department of Surgical Sciences (NDS) have been awarded highly competitive Clinical Research Training Fellowships by the Medical Research Council (MRC).

WHO Classification of Tumours programme awarded large grant to improve classification and evidence base

A new project titled Mapping the Evidence for the World Health Organization (WHO) Classification of Tumours: A Living Evidence Gap Map by Tumour Type (WCT EVI MAP), led by researchers of the WHO Classification of Tumours programme at the International Agency for Research on Cancer (IARC), has received a grant of €3.5 million from the European Commission. This four-year project, which will be undertaken in collaboration with six other international institutions, including Oxford University's Nuffield Department of Surgical Sciences (NDS), was launched on 1 July 2022.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.